The Antiemetics And Antinauseants Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Antiemetics And Antinauseants Market:
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
According to The Business Research Company’s Antiemetics And Antinauseants Global Market Report 2024, The antiemetics and antinauseants market size has grown steadily in recent years. It will grow from $7.75 billion in 2023 to $8.09 billion in 2024 at a compound annual growth rate (CAGR) of 4.3%. The growth in the historic period can be attributed to historical branding and market competition, historical treatment preferences, economic conditions, historical global health events, medical advancements and research.
The antiemetics and antinauseants market size is expected to see steady growth in the next few years. It will grow to $9.46 billion in 2028 at a compound annual growth rate (CAGR) of 4.0%. The growth in the forecast period can be attributed to research and development initiatives, economic factors, market competition and industry trends, changing disease patterns, healthcare policies and regulations. Major trends in the forecast period include increased focus on patient experience, changing healthcare policies, consumer preference for non-invasive treatments, rising prevalence of chemotherapy and pregnancy-related nausea, emergence of targeted therapies.
The antiemetics and antinauseants market is driven by the increase in the prevalence rate of cancer. Chemotherapy is one of the most recommended treatments to cure cancer, and chemotherapy-induced nausea and vomiting (CINV) are some of the side effects of the treatment. Antiemetics can help prevent CINV in about 60%-70% of patients. According to the WHO reports, the incidence of cancer globally has risen to 18.1 million new cases and 9.6 million deaths. According to another report by the Centers for Disease Control and Prevention, about 650,000 cancer patients in the USA receive chemotherapy in an outpatient oncology clinic each year. The CINV caused by chemotherapy treatments is cured by using antiemetic and antinauseant drugs like Dolasetron (Anzemet), Ranitidine (Zantac), and other serotonin 5-HT3 receptor types of antagonists. An increase in the incidence of cancer will increase demand for antiemetics and antinauseants, thereby driving revenue for the market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2441&type=smp
The antiemetics and antinauseants market covered in this report is segmented –
1) By Drug: Dopamine antagonists, NK1 receptor antagonist, Antihistamines (H1 histamine receptor antagonists), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 receptor antagonists, Other Drug Types
2) By Application: Chemotherapy, Motion sickness, Gastroenteritis, General anaesthetics, Opioid analgesics, Dizziness, Pregnancy, Food poisoning, Emotional stress, Other Application Types
3) By End Users: Hospital, Medical Center, Clinic, Research Institutes
Manufacturers are exploiting nanotechnology in the antiemetics and antinauseants market to deliver therapeutic agents to specifically targeted sites in a controlled manner through Nanomedicine and Nano delivery systems. Nanomedicine is the medical application of nanotechnology which uses nanoparticles to enhance the action of the drug in treatment and nanotechnology is the design, characterization, production, and application of devices, structures, and systems by controlled manipulation of size and shape at the nanometer scale. The antiemetic and antinauseant drug manufacturers are inclining more toward the use of Nanomedicine or Nano drugs to make the drug effective and increase their revenues. For instance, Merck & Co., an American multinational pharmaceutical company manufactured Aprepitant under the brand name Emend. It is the first FDA-approved drug for the prevention of acute chemotherapy-induced nausea and vomiting (CINV) that uses nanotechnology to increase the absorption of the drug more easily and efficiently.
The antiemetics and antinauseants market report table of contents includes:
- Executive Summary
- Antiemetics And Antinauseants Market Characteristics
- Antiemetics And Antinauseants Market Trends And Strategies
- Antiemetics And Antinauseants Market - Macro Economic Scenario
- Global Antiemetics And Antinauseants Market Size and Growth
.
.
.
- Global Antiemetics And Antinauseants Market Competitive Benchmarking
- Global Antiemetics And Antinauseants Market Competitive Dashboard
- Key Mergers And Acquisitions In Antiemetics And Antinauseants Market
- Antiemetics And Antinauseants Market Future Outlook and Potential Analysis
- Appendix
Top Major Players :
- Pfizer Inc.
- Johnson & Johnson Services Inc.
- Hoffmann-La Roche Ltd.
- Merck & Co. Inc.
- AbbVie Inc.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
A recent report published by TheBusinessResearchCompany on Antiemetics And Antinauseants Market provides in-depth analysis of segments and sub-segments in the global as well as regional.The Antiemetics And Antinauseants Global Market Report 2020 which provides strategists, marketers and senior management with the critical information they need to assess the global antiemetics and antinauseants market.
the report covers the antiemetics and antinauseants market’s segments- dopamine antagonists, NK1 receptor antagonist, antihistamines (H1 histamine receptor antagonists), cannabinoids, benzodiazepines, anticholinergics, steroids, 5-HT3 receptor antagonists, chemotherapy, motion sickness, gastroenteritis, general anaesthetics, opioid analgesics, dizziness, pregnancy, food poisoning, emotional stress, hospital, medical center, clinic, and research institutes.
Antiemetics And Antinauseants Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 50+ geographies.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country.It also compares the market’s historic and forecast growth.
It covers all the regions, key developed countries and major emerging markets.
It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
Key PlayersSome of the key players in the Global Antiemetics Market are GSK (UK), Merck (US), Sanofi-Aventis (France), Pfizer Inc. (US), Mylan (US), Eli Lilly and Company (US), Johnson & Johnson (US), Baxter International (US), Dr. Reddy's Laboratories Inc. (India) and others.Market HighlightsAccording to MRFR analysis, Antiemetics Market is expected to register a CAGR of 6.6% during the forecast period of 2019 to 2025 and account for USD 6.7 Billion in 2025.The Global Antiemetics Market is expected to grow at a steady pace.
There are numerous antiemetics agents available for the treatment of nausea and vomiting, including; dopamine antagonists, anticholinergics, antihistamines, serotonin antagonists, and others.
According to a study, it is found that PONV occurs in nearly 30% of the general surgical population and up to 70% to 80% of high-risk surgical patients.
Europe is expected to account for the second-largest market in the global antiemetics market owing to well-developed research infrastructure, increasing healthcare awareness in the region, and high expenditure in pharmaceutical research.SegmentationThe Global Antiemetics Market has been segmented into agents, drug type, application, and distribution channel.By agents, the market has been segmented into dopamine antagonists, anticholinergics, antihistamines, serotonin antagonists, cannabinoids, and others.
Dopamine accounted for the largest market share majorly due to FDA approval for the maximum number of applicationBy drug type, the market is segmented into prescribed and OTC.
Asia-Pacific is expected to be the fastest-growing region due to the growing interest of major key players in entering emerging markets, increasing development in the pharmaceutical industry in this region.
Global Antiemetics Market Research Report 2019 covers competitive outlook including the Antiemetics market share and size, company profiles of the key participants operating in the market.
Antiemetics market report contains several important factors to advanced market intelligence which can help manufacturers in planning future strategies.Get Sample Copy of this Report – https://www.orianresearch.com/request-sample/1080956This report studies the global market size of Antiemetics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).This study presents the Antiemetics production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications.
History breakdown data from 2014 to 2019, and forecast to 2024.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.Complete report on Antiemetics Market report spread across 119 pages, profiling companies and supported with tables and figures available.Enquire more @ https://www.orianresearch.com/enquiry-before-buying/1080956In global market, the following companies are covered:BaxterNeuroDermRocheGlaxoSmithKlineFerringCSL BehringGrifolsAmgenCapricorAstraZenecaJanssenBritanniaOctapharma…Most important types of Antiemetics products covered in this report are:Phenothiazine DrugsAntihistaminesAnticholinergic DrugMost widely used downstream fields of Antiemetics market covered in this report are:FamilyHospitalOrder a copy of Global Antiemetics Market Report 2019 @ https://www.orianresearch.com/checkout/1080956Major Points from Table of Contents:Global Antiemetics Industry Market Research Report1 Antiemetics Introduction and Market Overview2 Industry Chain Analysis3 Global Antiemetics Market, by Type4 Antiemetics Market, by Application5 Global Antiemetics Production, Value ($) by Region (2014-2019)6 Global Antiemetics Production, Consumption, Export, Import by Regions (2014-2019)7 Global Antiemetics Market Status and SWOT Analysis by Regions8 Competitive Landscape9 Global Antiemetics Market Analysis and Forecast by Type and Application10 Antiemetics Market Analysis and Forecast by Region11 New Project Feasibility Analysis12 Research Finding and Conclusion13 AppendixAbout Us:Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web.
Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers.
We continuously update our repository so as to provide our clients easy access to the world's most complete and current database of expert insights on global industries, companies, and products.
